Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma

Clinical trial NCT06461624 · RECRUITING

Trial details

NCT number: NCT06461624
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2024-07-01
Primary completion: 2027-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.